Cybin
Why Robinhood?
You can watch Cybin and buy or sell other stocks, ETFs, and their options commission-free!About CYBN
Helus Pharma, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds.
CYBN Key Statistics
Stock Snapshot
The current Cybin(CYBN) stock price is $11.70, with a market capitalization of 725.21M. The stock trades at a price-to-earnings (P/E) ratio of -2.76.
During the trading day, Cybin(CYBN) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Cybin(CYBN) stock has reached 0, versus its average volume of 1.49M.
Over the past 52 weeks, Cybin(CYBN) stock has traded between a high of $15.15 and a low of $3.76.
Over the past 52 weeks, Cybin(CYBN) stock has traded between a high of $15.15 and a low of $3.76.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.